Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Corticosteroids and muscle wasting: role of transcription factors, nuclear cofactors, and hyperacetylation Hasselgren PO; Alamdari N; Aversa Z; Gonnella P; Smith IJ; Tizio SCurr Opin Clin Nutr Metab Care 2010[Jul]; 13 (4): 423-8PURPOSE OF REVIEW: The purpose of this review is to discuss novel insight into mechanisms of glucocorticoid-regulated muscle wasting, in particular the role of transcription factors and nuclear cofactors. In addition, novel strategies that may become useful in the treatment or prevention of glucocorticoid-induced muscle wasting are reviewed. RECENT FINDINGS: Studies suggest that glucocorticoid-induced upregulation of the transcription factors Forkhead box O 1 and CCAAT/enhancer-binding protein beta and downregulation of MyoD and myogenin are involved in glucocorticoid-induced muscle wasting. In addition, glucocorticoid-induced hyperacetylation caused by increased expression of the nuclear cofactor p300 and its histone acetyl transferase activity and decreased expression and activity of histone deacetylases plays an important role in glucocorticoid-induced muscle proteolysis and wasting. Other mechanisms may also be involved in glucocorticoid-induced muscle wasting, including insulin resistance and store-operated calcium entry. Novel potential strategies to prevent or treat glucocorticoid-induced muscle wasting include the use of small molecule histone deacetylase activators, dissociated glucocorticoid receptor agonists, and 11beta-hydroxysteroid dehydrogenase type 1 inhibitors. SUMMARY: An increased understanding of molecular mechanisms regulating glucocorticoid-induced muscle wasting will help develop new strategies to prevent and treat this debilitating condition.|Acetylation[MESH]|Animals[MESH]|CCAAT-Enhancer-Binding Protein-beta/genetics/metabolism[MESH]|E1A-Associated p300 Protein/metabolism[MESH]|Forkhead Transcription Factors/genetics/metabolism[MESH]|Gene Expression Regulation/*drug effects[MESH]|Glucocorticoids/*adverse effects[MESH]|Histone Deacetylases/metabolism[MESH]|Humans[MESH]|Muscular Atrophy/drug therapy/*genetics/metabolism[MESH]|MyoD Protein/genetics/metabolism[MESH]|Myogenin/genetics/metabolism[MESH]|Transcription Factors/*metabolism[MESH] |